Inhibition of cytoplasmic antigen, glucose-6-phosphate dehydrogenase, by V(H)-C(H)1, an intracellular Fd fragment antibody derived from a semisynthetic Fd fragment phage display library

Journal of Molecular Biology

Volumn 289, Issue 1, 1999, Pages 41-55

  Mulligan Kehoe, Mary Jo ^a,b   Russo, Angelo ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Fd fragment; Intracellular inactivation; Phage display; Proteasomal degradation; Random CDRIII library

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE REGULATED PROTEIN; PROTEASOME;

AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ARTICLE; BINDING SITE; CELL STRAIN V 79; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING;

EID: 0033612220     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2749     Document Type: Article

References (75)

1. Bachmair A., Varshavsky A. The degradation signal in a short-lived protein. Cell. 56:1989;1019-1032.
2. Barbas C. III, Kang A. S., Lerner R. A., Benkovic S. J. Assembly of combinatorial antibody libraries on phage display surfaces: the gene Ill site. Proc. Natl Acad. Sci. USA. 88:1991;7978-7982.
3. Barbas C. F. III, Bain J. D., Hoekstra D. M., Lerner R. A. Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. Proc. Natl Acad. Sci. USA. 89:1992;4457-4461.
4. Berek C., Milstein C. The dynamic nature of the antibody repertoire. Immunol. Rev. 105:1988;5-26.
5. Bergmeyer H. U., Gawehn K., Grassl M. Enzymes as biochemical reagents. Methods of Enzymatic Analysis. 1974;Verlag Chemie International.
6. Better M., Chang C. P., Robinson R. R., Horwitz A. H. Escherichia coli secretion of an active chimeric antibody fragment. Science. 240:1988;1041-1104.
7. Biocca S., Pierandrei-Amaldi P., Campioni N., Cattaneo A. Intracellular immunization with cytosolic recombinant antibodies. BioTechnology. 12:1994;396-399.
8. Bird R. E., Hardman K. D., Jacobson J. W., Johnson S., Kaufman B. M., Lee S-M., Lee T., Pope S. H., Riordan G. S., Whitlow M. Single-chain antigen binding proteins. Science. 242:1988;423-426.
9. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
10. Chen J.-D., Yang Q., Yang A.-G., Marasco W. A., Chen S.-Y. Intra- and extracellular immunization against FIIV-1 infection with lymphocytes transduced with an AAV vector expressing a human anti-gp120 antibody. Human Gene Therapy. 7:1996;1515-1525.
11. Chen S-Y., Khouri Y., Bagley J., Marasco W. A. Combined intra- and extracellular immunization against Human Immunodeficiency Virus Type 1 infection with a human anti-gpl2O antibody. Proc. Natl Acad. Sci. USA. 91:1994;5932-5936.
12. Ciechanover A. J., Schwartz A. L. How are substrates recognized by the ubiquitin-mediated proteolytic system? Trends Biochem. Sci. 14:1989;483-488.
13. Clackson T., Hoogenbom H. R., Griffiths A. D., Winter G. Making antibody fragments using phage display libraries. Nature. 352:1991;624-628.
14. Collett T. A., Roben P., O'Kennedy R., Barbas C. F. III, Burton D. R. A binary plasmid system for shuffling combinatorial antibody libraries. Proc. Natl Acad. Sci. USA. 89:1992;10026-10030.
15. Cullen B. R., Lomedico P. T., Ju G. Transcriptional interference in avian retroviruses-implications for the promoter insertion model of leukaemogenesis. Nature. 307:1984;241-245.
16. Davies D. R., Padlam E. A., Segal D. M. Three-dimension structure of immunoglobulins. Annu. Rev. Biochem. 44:1975;639-667.
17. Duan L., Zhang H., Gakes J. W., Bagasra O., Pomerantz R. J. Molecular and virological effects of intracellular anti- Rev single chain variable fragments on their expression of various human immunodeficiency virus-I strains. Human Gene Therapy. 5:1994;1315-1324.
18. Early P., Huang H., Davis M., Calame K., Hood L. An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell. 19:1980;981-992.
19. Emerman M., Temin H. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell. 39:1984;459-467.
20. Fenteany G., Standaert R. F., Lane W. S., Choi S., Corey C. E. J., Schreiber S. L. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 268:1995;726-731.
21. Glotzer M., Murray A. W., Kirschner M. W. Cycin is degraded by the ubiquitin pathway. Nature. 348:1991;132-13.
22. Gottesman S., Maurizi M. R. Regulation by proteolysis: energy dependent proteases and their targets. Microbiol. Rev. 56:1992;592-621.
23. Gussow D., Ward E. S., Griffiths A. D., Jones P. T., Winter G. Generating binding activities from Escherichia coli by expression of a repertoire of immunoglobulin variable domains. Cold Spring Harbor Symposia on Quantitative Biology. 1989;Cold Spring Harbor Press.
24. Honjo T., Habu S. Origin of immune diversity: genetic variation and selection. Annu. Rev. Biochem. 54:1985;803-830.
25. Hoogenboom H., Winter G. By-passing immunization. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J. Mol. Biol. 227:1992;381-388.
26. Hoogenboom H. R., Griffiths A. D., Johnson K. S., Chiswell D. J., Hudson P., Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucl. Acids Res. 19:1991;4133-4137.
27. Huse W. D., Sastry L., Iverson S. A., Kang A. S., Alting-Mees M., Burton D. R., Benkovic S. J., Lerner R. A. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science. 246:1989;1275-1281.
28. Huston J. S. D., Levinson D., Mudgett-Hunter M., Tai M-S., Novotny J., Margolies M. N., Ridge R. J., Bruccoleri R., Haber E., Crea R., Oppermann H. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single chain Fv analogue produced in E. coli. Proc. Natl Acad. Sci. USA. 85:1988;5879-5883.
29. Huston J. S., Mudgett-Hunter M., Tai M-S., McCartney J., Warren F., Haber E., Oppermann H. Protein engineering of single-chain Fv analogs and fusion proteins. Methods Enzymol. 203:1991;46-88.
30. Huston J. S., McCartney J. E., Tai M-S., Mottola-Hartshorn C., Jin D., Warren F., Keck P., Oppermann H. Medical applications of single-chain antibodies. Int. Rev. Immunol. 10:1993;195-217.
31. 2divalent form of anti- cerb B-2 single-chain Fv. Cell Biophys. 24/25:1994;267-278.
32. Ichihara Y., Matsuoka H., Kurosawa Y. Organization of human immunoglobulin heavy chain diversity gene loci. EMBO J. 7:1988;4141-4150.
33. Johnson S., Bird R. E. Construction of single-chain Fv derivatives of monoclonal antibodies and their production in Escherichia coli. Methods Enzymol. 203:1991;88-98.
34. Kabat E. A., Wu T. T., Perry H. M., Gottesman K. S., Foeller C. Sequences of Proteins of Immunological Interest. 1991;U.S. Department of Health and Human Services, Public Health ServiceNational Institutes of Health, Bethesda.
35. Kang A. S., Barbas C. F., Janda K. D., Benkovic S. J., Lerner R. A. Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc. Natl Acad. Sci. USA. 88:1991;4363-4366.
36. Kochs C., Rajewsky K. Stable expression and somatic hypermutation of antibody V regions in B-cell developmental pathways. Annu. Rev. Immunol. 7:1989;537-559.
37. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
38. Kohler G., Milstein C. Derivation of specific antibody-producing tissue cultures and tumor lines by cell fusion. Eur. J. Immunol. 6:1976;511-519.
39. Kornitzer D., Raboy B., Kulka R. G., Fink G. R. Regulated degradation of the transcriptional factor Gcn4. EMBO J. 13:1994;6021-6030.
40. Kozak M. Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucl. Acids Res. 9:1981;5233-5262.
41. Levin R., Mhashilkar A. M., Dorfman I., Bukovsky A., Zani C., Bagley J., Hinkula J., Niedrig M., Albert J., Wahren B., Gottlinger H. G., Marasco W. A. Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. Mol. Med. 3:1997;96-110.
42. Levy-Mintz P., Duan L., Zhang H., Hu B., Dornadula G., Zhu M., Kulkosky J., Bizub-Bender D., Skalka A. M., Pomerantz R. J. Intracellular expression of single-chain variable fragments to inhibit early stages of viral life cycle by targeting Human Immunodeficiency Virus type 1 integrase. J. Virol. 70:1996;8821-8832.
43. Lorimer I. A. J., Keepler-Hafkemeyer A., Beer R. A., Pegram C. N., Bigner D. D., Pastan I. Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display. Proc. Natl Acad. Sci. USA. 93:1996;14815-14820.
44. Maciejewski J. P., Weichold F. F., Young N. S., Cara A., Zella D., Reitz M. S. Jr, Gallo R. C. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nature Med. 1:1995;667-673.
45. Marasco W. A. Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy. Immunotechnology. 1:1995;1-19.
46. Marasco W. A., Haseltine W. A., Chen S. Y. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gpl20 single-chain antibody. Proc. Natl Acad. Sci. USA. 90:1993;7889-7893.
47. Marks J. D., Griffiths A. D., Malmqvist M., Clackson T., Bye J. M., Winter G. By-passing immunization: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:1992;581-597.
48. McCafferty J., Griffiths A. D., Winter G., Chiswell D. J. Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 348:1990;552-554.
49. Mhashilkar A. M., Bagley J., Chen S. Y., Szilvay A. M., Helland D. G., Marasco W. A. Inhibition of HIV-1 tat -mediated LTR transactivation and HIV-1 infection by anti- tat single chain intrabodies. EMBO J. 14:1995;1542-1551.
50. Mhashilkar A. M., Biswas D. K., LaVecchio J., Pardee A. B., Marasco W. A. Inhibition of Human Immunodeficiency Virus Type I replication in vitro by a novel combination of anti-tat single-chain intrabodies and NFkB antagonists. J. Virol. 71:1997;6486-6494.
51. Milstein C. Antibodies: a paradigm for the biology of molecular recognition. Proc. Roy. Soc. London. 239:1990;1-16.
52. O. Coux, K., Tanaka K., Goldberg A. L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:1996;801-847.
53. Orlandi R., Gussow D. H., Jones P. T., Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl Acad. Sci. USA. 86:1989;3833-3837.
54. Persson M. A., Caothien R. H., Burton D. R. Generation of diverse high affinity human monoclonal antibodies by repertoire cloning. Proc. Natl Acad. Sci. USA. 88:1991;2432-2436.
55. Philibert R. A., Hawkins G. A., Damschroder-Williams P., Stubblefield B. K., Martin B. M., Ginnis E. I. Direct sequencing of trinucleotide repeats from cosmid genomic DNA template. Anal. Biochem. 225:1995;372-374.
56. Raag R., Whitlow M. Single-chain Fvs. FASEB J. 9:1995;73-80.
57. Rechsteiner M. Regulation of enzyme levels of proteolysis: the role of PEST regions. Advan. Enzyme Regul. 27:1988;135-151.
58. Rogers S., Wells R., Rechsteiner M. Amino acid sequences common to rapidly degrading proteins: the PEST hypothesis. Science. 234:1986;364-368.
59. Rondon I. J., Marasco W. A. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu. Rev. Microbiol. 51:1997;257-283.
60. Sakano H., Maki R., Kurosawa Y., Roeder W., Tonegawa S. Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes. Nature. 286:1980;676-683.
61. Sakano H., Kurosawa Y., Weigert M., Tonegawa S. Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes. Nature. 290:1981;562-565.
62. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
63. Sastry L., Alting-Mees M., Huse W. D., Short J. M., Sorge J. A., Hay B. N., Janda K. D., Benkovic S. J., Lerner R. A. Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: construction of a heavy chain variable region-specific cDNA library. Proc. Natl Acad. Sci. USA. 86:1989;5728-5732.
64. Schroeder H. W., Wang J. Y. Preferential utilization of conserved immunoglobulin heavy chain variable gene segments duting human fetal life. Proc. Natl Acad. Sci. USA. 87:1990;6146-6150.
65. Seidman J. G., Leder P. The arrangement and rearrangement of antibody genes. Nature. 276:1978;790-795.
66. Shaheen F., Duan L., Zhu M., Bagasra O., Pomerantz R. J. Targeting human immunodeficiency virus type I reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle. J. Virol. 70:1996;3392-3400.
67. Skerra A., Pluckthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science. 240:1988;1038-1040.
68. Tomlinson I. M., Walter G., Marks J. D., Liewelyn M. B., Winter G. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J. Mol. Biol. 227:1992;776-798.
69. Tonega W. Somatic generation of antibody diversity. Nature. 302:1983;575-581.
70. Varshavsky A. The N-end rule. Cell. 69:1992;725-735.
71. Ward E. S. Antibody engineering: the use of Escherichia coli as an expression host. FASEB J. 6:1992;2422-2427.
72. Ward E. S., Gussow D., Griffiths A. D., Jones P. R., Winter G. Binding activities of a repertoire of single immunoglobulin variable domains secreted fromEscherichiacoli. Nature. 341:1989;544-546.
73. Werge T. M., Biocca S., Cattaneo A. Cloning and intracellular expression of a monoclonal antibody to the p2lras protein. FEBS Letters. 274:1990;193-198.
74. Winter G., Griffiths A. D., Hawkins R. E., Hoogenboom H. R. Making antibodies by phage display technology. Annu. Rev. Immunol. 12:1994;433-455.
75. Wu Y., Duan L., Zhu M., Hu B., Kubota S., Bagasra O., Pomerantz R. J. Binding of intracellular anti-Rev single-chain variable fragments to different epitopes of Human Immunodeficiency Virus Type 1 Rev: variations in viral inhibition. J. Virol. 70:1996;3290-3297.